Corrado Barbui

1997–2025 年に発表

159
論文数
26,676
被引用数
78
h 指数
148
i10 指数

被引用数

Corrado Barbui の年別被引用数1999 年: 被引用 1 件2000 年: 被引用 1 件2001 年: 被引用 4 件2002 年: 被引用 8 件2003 年: 被引用 13 件2004 年: 被引用 12 件2005 年: 被引用 38 件2006 年: 被引用 34 件2007 年: 被引用 66 件2008 年: 被引用 45 件2009 年: 被引用 105 件2010 年: 被引用 96 件2011 年: 被引用 108 件2012 年: 被引用 139 件2013 年: 被引用 177 件2014 年: 被引用 165 件2015 年: 被引用 196 件2016 年: 被引用 163 件2017 年: 被引用 205 件2018 年: 被引用 174 件2019 年: 被引用 647 件2020 年: 被引用 767 件2021 年: 被引用 848 件2022 年: 被引用 709 件2023 年: 被引用 534 件2024 年: 被引用 1,019 件2025 年: 被引用 482 件2026 年: 被引用 25 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,070 件、この内訳の 16.2%イギリス: 引用元論文 1,451 件、この内訳の 11.4%ドイツ: 引用元論文 753 件、この内訳の 5.9%中国: 引用元論文 723 件、この内訳の 5.7%イタリア: 引用元論文 713 件、この内訳の 5.6%カナダ: 引用元論文 627 件、この内訳の 4.9%オーストラリア: 引用元論文 531 件、この内訳の 4.2%オランダ: 引用元論文 428 件、この内訳の 3.4%スイス: 引用元論文 368 件、この内訳の 2.9%スペイン: 引用元論文 350 件、この内訳の 2.7%スウェーデン: 引用元論文 279 件、この内訳の 2.2%日本: 引用元論文 275 件、この内訳の 2.2%
0%16.2%その他 32.7%

分野

  • Medicine59.5%
  • Psychology18.1%
  • Neuroscience9%
  • Biochemistry, Genetics and Molecular Biology3.3%
  • Health Professions3%
  • Decision Sciences1.2%
  • その他5.9%

トピック

  • Schizophrenia research and treatment6%
  • Treatment of Major Depression4.3%
  • Liver Disease Diagnosis and Treatment3.5%
  • Bipolar Disorder and Treatment2.7%
  • Tryptophan and brain disorders2.6%
  • Mental Health Treatment and Access2.5%
  • その他78.4%

共著者

全論文

検索で開く
  1. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

    著者: , , , , - Journal of Hepatology 2016 被引用: 1,410

  2. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis

    著者: , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2018 被引用: 1,333

  3. Imputing missing standard deviations in meta-analyses can provide accurate results

    著者: , , , , - Journal of Clinical Epidemiology 2005 被引用: 1,561

  4. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis

    著者: , , , , , , , , , , , , , , , , - The Lancet 2022 被引用: 413

  5. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

    著者: , , , , , , , , , , , , , , - The Lancet 2013 被引用: 2,537

  6. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jae Il Shin, Elena Dragioti - BMJ 2023 被引用: 245

  7. Reducing the Risk of Cognitive Decline and Dementia: WHO Recommendations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Frontiers in Neurology 2022 被引用: 201

  8. Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - World Psychiatry 2023 被引用: 140

  9. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials

    著者: , , , , , , , , - Journal of Affective Disorders 2015 被引用: 393

  10. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis

    著者: , , , , , , , , , , , , , , , - PLoS Medicine 2020 被引用: 342

  11. Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality

    著者: , , , , - JAMA Network Open 2024 被引用: 88

  12. Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review

    著者: , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2020 被引用: 341

  13. Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis

    著者: , , , , , , , , , , , , - The Lancet Psychiatry 2021 被引用: 265

  14. Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 participants

    著者: , , , , , , , , , , , , - World Psychiatry 2022 被引用: 115

  15. Imputing response rates from means and standard deviations in meta-analyses

    著者: , , , , - International Clinical Psychopharmacology 2004 被引用: 350

  16. Psychological and Psychosomatic Symptoms of Second Victims of Adverse Events: a Systematic Review and Meta-Analysis

    著者: , , , , , - Journal of Patient Safety 2019 被引用: 232

  17. Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studies

    著者: , , , , - The British Journal of Psychiatry 2022 被引用: 141

  18. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

    著者: , , , , , , , , , , , - The Lancet 2009 被引用: 1,656

  19. Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System

    著者: , , , , - Psychotherapy and Psychosomatics 2020 被引用: 131

  20. An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Molecular Psychiatry 2023 被引用: 68

  21. Pharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis

    著者: , , , , , , , , , , - The British Journal of Psychiatry 2015 被引用: 410

  22. Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta‐analysis

    著者: , , , , , , , , , , , - World Psychiatry 2018 被引用: 197

  23. Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database

    著者: , , , , , , , , , , - Drug Safety 2022 被引用: 57

  24. COVID-19 and common mental health symptoms in the early phase of the pandemic: An umbrella review of the evidence

    著者: , , , , , , , , , , , , , , , , , , - PLoS Medicine 2023 被引用: 136